Local anesthetics have been used for temporary loss of pain, which limits their clinical application due to the neurotoxicity and short half-lives. In this present investigation, we have developed a novel k-carrageenan/alginate (k-CN/AGT) hydrogel loaded with Ropivacaine (RVN) to achieve a sustained release system. The synthesized k-CN/AGT hydrogels were examined for structural characterization, morphology, and mechanical properties. The observed studies revealed hydrogel has a suitable porous structure (0.5 to 5 µm) and effective swelling ratio with controlled in vitro release kinetics. The in vitro biocompatibility test on human dermal fibroblast cells confirmed that hydrogel has a nontoxic nature. The anesthetic activity of k-CN/AGT-RVN hydrogels was evaluated in vivo and compared with commercial formulations. Ex vivo permeation efficiency of k-CN/AGT-RVN hydrogels surpassed that of the RVN. As a result, the study demonstrated that k-CN/AGT-RVN hydrogels have the potential to prolong the effects of local anesthesia, offering a promising avenue for effective pain management.
Read full abstract